Characterization of adverse effects of GLP-1 receptor agonist exposures reported to US Poison Centers 

April 29, 2020

Abstract: Background: Glucagon Like Peptide-1 (GLP-1) agonists are an increasingly used class of medications in the treatment of Type 2 diabetes and obesity. To date, there…